Health IT companies across revenue cycle management, behavioral health, cybersecurity, supply chain and other areas highlight new developments and share how they have responded to the challenges of the Covid-19 pandemic.
The four companies are collaborating under a program that stems from a law that Congress passed in 2013 to develop an electronic pharmaceutical tracking system.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
As pharma continues to close the gap between the operational and analytical needs of their business, they can look to other industries for best practices.
Black Granite Capital led the round, which the company, Jump Technologies, will use to expand its sales efforts and support product development.
The organization offers a platform for member hospitals to buy and sell healthcare products and medical equipment with each other.
Parachute Health has raised a Series B round on the heels of another fundraise earlier this year for a total of $15 million. Insight Venture Partners became the latest investors to back the business
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
DSV, a global logistics business, notes on its website that supply chain visibility is the biggest challenge to getting supplies delivered on time. Parachute Health is one company that is using its technology to address this challenge and ensure patients get medical equipment on time.
A research paper from Trend Micro and HITRUST looked at exposed medical devices and supply chains, both of which are neglected network risks in hospitals.
Madison, Wisconsin-based Pinpoint Software has released its Date Check Pro for Healthcare software, which seeks to help hospitals reduce medical supply waste by improving their expiration date management technique.
Consolidation, driven by cost-cutting, drug company mergers and outsourcing of manufacturing, has prompted hospital pharmacists and health policy experts to fear that one misstep could spell disaster for patients.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.